Mytos - Home

Live with Multibillion Dollar Biotechs on both US coasts

The Mytos Platform fully automates manufacture of any human cell type

A screenshot of an app alongside an image of a rack of multiple devices

Mytos transforms Cell Culture from Artisan to Automated

Scalable

Scale cell production without having to hire

High Quality

Consistent high quality cells everytime

Robust

No more failed cell batches due to contamination or human error

High Productivity

1 technician can produce the cell output of 10 scientists working manually

Cells are the Foundation of All New Medicines

For traditional drugs, cells are the testbed. For Cell Therapies, cells are the medicine.

Drug Discovery

$5B

40,000 machines worth of cell production across drug development

Cell Therapy

$20B

2 million patient cell batches a year by 2030

Mytos Platform is live with our Pharma customers

Q1 2019

Platform grows primary suspension cells

Q2 2021

Platform grows iPSCs - the hardest to grow human cell type

Q2 2022

Final pre-launch pilots

Q1 2023

Mytos Platform live with Pharma customers

Our Team

Bringing together some of the best hardware engineers, software engineers, and biologists to invent the infrastructure for biotech.

OUR TEAM

Photo of the Mytos team outside the office

Infrastructure for Cell Manufacturing